10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2018 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2018 10-K (Filed: Feb 19, 2019) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2018 | Dec 31, 2017 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents (Note 7) | $ 7,998,200 | 6,536,200 |
| Short-term investments (Note 7) | 88,200 | 1,497,900 |
| Accounts receivable, net of allowances of $32.5 (2018) and $38.7 (2017) | 5,246,500 | 4,546,300 |
| Other receivables | 958,400 | 715,900 |
| Inventories (Note 6) | 4,111,800 | 4,458,300 |
| Prepaid expenses and other | 2,146,500 | 1,447,500 |
| Total current assets | 20,549,600 | 19,202,100 |
| Other Assets | ||
| Investments (Note 7) | 2,020,700 | 5,678,800 |
| Goodwill (Note 8) | 4,347,500 | 4,370,100 |
| Other intangibles, net (Note 8) | 3,521,000 | 4,029,200 |
| Deferred tax assets (Note 13) | 2,657,700 | 1,166,400 |
| Sundry | 1,892,400 | 1,707,900 |
| Total other assets | 14,439,300 | 16,952,400 |
| Property and equipment, net (Note 9) | 8,919,500 | 8,826,500 |
| Total assets | 43,908,400 | 44,981,000 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt (Note 10) | 1,131,200 | 3,706,600 |
| Accounts payable | 1,412,300 | 1,410,700 |
| Employee compensation | 1,054,500 | 997,900 |
| Sales rebates and discounts | 5,021,900 | 4,465,100 |
| Dividends payable | 650,800 | 590,600 |
| Income taxes payable (Note 13) | 404,000 | 532,900 |
| Other current liabilities | 2,213,400 | 2,832,100 |
| Total current liabilities | 11,888,100 | 14,535,900 |
| Other Liabilities | ||
| Long-term debt (Note 10) | 11,639,700 | 9,940,500 |
| Accrued retirement benefits (Note 14) | 2,911,300 | 3,513,900 |
| Long-term income taxes payable (Note 13) | 3,724,600 | 3,776,500 |
| Other noncurrent liabilities | 2,835,600 | 1,546,300 |
| Total other liabilities | 21,111,200 | 18,777,200 |
| Commitments and Contingencies (Note 15) | ||
| Eli Lilly and Company Shareholders' Equity (Notes 11 and 12) | ||
| Common stockno par value Authorized shares: 3,200,000 Issued shares: 1,057,639 (2018) and 1,100,672 (2017) | 661,000 | 687,900 |
| Additional paid-in capital | 6,583,600 | 5,817,800 |
| Retained earnings | 11,395,900 | 13,894,100 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss (Note 16) | (5,729,200) | (5,718,600) |
| Cost of common stock in treasury | (69,400) | (75,800) |
| Total Eli Lilly and Company shareholders' equity | 9,828,700 | 11,592,200 |
| Noncontrolling interests | 1,080,400 | 75,700 |
| Total equity | 10,909,100 | 11,667,900 |
| Total liabilities and equity | 43,908,400 | 44,981,000 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |